Thyme Care joined the Unicorn Club in 2025 after raising a $97 million Series D funding round, reaching a $1.5 billion valuation. Headquartered in New York, New York, United States, Thyme Care delivers personalized oncology care by combining advanced data analytics, care coordination, and patient-centric clinical programs.
The platform supports patients across the cancer journey, integrating diagnostics, treatment planning, and continuous monitoring to improve outcomes and reduce complications.
Keep reading to learn how Thyme Care became a $1.5 billion leader in personalized oncology care.
What Is Thyme Care and What Does It Do?
Founded in 2020, Thyme Care is an oncology platform that provides personalized cancer care to patients across multiple cancer types. The company uses data-driven treatment plans, predictive analytics, and coordinated care teams to optimize therapy decisions.
Thyme Care integrates patient diagnostics, physician guidance, and ongoing monitoring to improve outcomes and enhance the patient experience. Its care model ensures continuity of care and better management of complex oncology treatments.
How Much Funding Has Thyme Care Raised?
1. Series D Round
- Amount Raised: $97 million
- Date: 2025
- Valuation: $1.5 billion
- Lead Investors: a16z, Concord Health Partners
- Purpose: Expand personalized cancer care programs, scale clinical operations, and enhance data-driven oncology tools
2. Earlier Rounds (Seed to Series C)
- Cumulative Funding: ~$183 million
- Key Investors: a16z, Concord Health Partners, and other early-stage investors
- Purpose: Build a core oncology platform, launch pilot programs, and expand the care network
Total Funding Raised: ~$280 million
Latest Funding Date: 2025
Latest Known Valuation: $1.5 billion
Key Investors
- a16z
- Details: Venture capital firm investing in healthcare and technology companies
- Focus Areas: Healthtech, digital health, oncology platforms, and data-driven therapeutics
- Concord Health Partners
- Details: Growth stage investment firm focused on healthcare innovation
- Focus Areas: Oncology care, patient-centric platforms, clinical solutions, and care delivery technology
Where Is Thyme Care’s Headquarters?
Thyme Care is headquartered in New York, New York, United States, serving as the hub for clinical operations, technology development, care coordination, and patient management.
What’s Next for Thyme Care?
Thyme Care plans to expand its personalized oncology programs, enhance predictive analytics for treatment decisions, and grow partnerships with hospitals and healthcare networks. The company is investing in AI tools and care coordination systems to improve patient outcomes and scale personalized cancer care nationally.
Get Investor and Funding Insights with TexAu
TexAu provides verified investor and funding data for companies like Thyme Care. Explore insights on personalized oncology, healthtech platforms, and high-growth cancer care startups.
Sign up for Free to access real-time investor and funding intelligence.
